$MRNA

MRNAModerna Inc.

What are people saying about Moderna (MRNA) stock on YouTube?

In the past 30 days (As of 11-18), 5 YouTube channels discussed Moderna (MRNA) in 10 entries. Most recent: Schwab Network, 2026-11-05.

All takes and content in this window

As of 11-18
11-05
Schwab NetworkPublished 2026-11-05
“The Big 3: HCA, ISRG, MRNA”
$MRNANo side taken
AI summary · The speaker likes MRNA, citing Phase 3 data showing a Keytruda-partnered drug cuts skin-cancer-related deaths by about 42% and an upward trend since the start of this year, though not a long-term upward trend. But it failed near old highs around 255 and RSI is unresolved between rising and falling trendlines; a breakout beyond either is needed to clarify bullish vs bearish direction, and a break below the 238.25 5-day EMA could open 219.

Your last name here is also in the healthcare sector, but it's a pharmaceutical company that has fallen a little more than some of the others, down 4.3% for Moderna, which has been making headlines a lot so far this year.

Well, the big picture for Moderna: everyone knows them from their COVID vaccine, but they also have some cool things they're working on, like the partnership with Keytruda and the drug they've provided that's reached Phase 3, which currently shows it can reduce skin cancer-related deaths by about 42%.

So, this is good news. So, I like Moderna in a long-term trend, I shouldn't say a long-term upward trend. It has been on an upward trend since the beginning of this year.

11-04
Meet KevinPublished 2026-11-04
“The Stock Market & Morning After Election 2026.”
$MRNABullish
10-31
Meet KevinPublished 2026-10-31
“You've been WARNED.”
$MRNABullish
10-30
BenzingaPublished 2026-10-30
“$INTC Plunges 26%, $AMZN Drops 6% After Q3 Earnings | PreMarket Playbook | October 30, 2026”
$MRNABearish
AI summary · MRNA is not a stock to hold: it has never made any money and is a 'flim flam' company, though intraday trading in and out is fine. It has looked strong — a 545% run, then a William Blair downgrade to market perform — and 180 was a good buy-the-dip entry.

MRNA, only down a couple.

Wow. MRNA. Yeah. Where is mRNA? mRNA is not going down. William Blair takes a shot at Madna stock downgrade to market outperform after 545% run. That was October 27th, so that's not Yeah, that that looks strong for sure.

Uh, what do you think of MNA MRNA? It's just looking good. You know, that was such a buy the dip at 180. I got involved at 180. I didn't hold it long enough though when it went down from 240 on the leaked news. That was that was a good opportunity.

10-23
The Motley FoolPublished 2026-10-23
“Moderna CEO Reveals His Massive Plans for Cancer, AI & Beyond!!”
$MRNABullish
AI summary · The host expects to keep adding to his Moderna position, arguing the market misprices its platform: at a typical 10% industry approval rate the stock would be overvalued, but the platform should lift success rates in each new disease area, with autoimmune value not yet in the share price.

Since we only have 3 hours, I'll start asking questions right away. Okay, let's start by explaining Moderna's basic technology in a way that a tenth-grade student who hates science can understand.

Oh, come on, man. You can't hate science in high school. Well, very simply, as many of you have learned during the pandemic, messenger RNA (mRNA) is an information molecule. It consists of four letters, just as all software consists of zeros and ones.

Schwab NetworkPublished 2026-10-23
“Friday's First Moves: MRNA Cancer Vaccine Trial Leaks, DECK Earnings, NCLH Downgrade”Cited source: analysts
$MRNANo side taken
Schwab NetworkPublished 2026-10-23
“WDC & BE Slide After Earnings as Crude Crosses $100; MRNA Cancer Vaccine Data Leak”
$MRNANo side taken
AI summary · Moderna's leaked phase 3 cancer-vaccine data showed a 42% reduction in recurrence/death risk vs 40% expected; some hoped for above 50%, and survival data had not leaked. The stock fell partly after a sharp prior rise; the speaker calls the leaked results overall positive, pending final results due end of week.

Okay, let's move on to talking about a big stock in the Nasdaq index. Not so much today, but yesterday. This is the company "Moderna". It's a completely different story from technology stock trading here.

There was a lot of optimism ahead of what would happen this weekend. We are supposed to get the results of the cancer vaccine trials. We have obtained the first stage and the second stage.

There was a leak yesterday that caused the stock to drop. Tell us about some of the price movements that are happening here.

10-20
Meet KevinPublished 2026-10-20
“The NEXT Frontier: THESE 3 Stocks Boom”
$MRNABullish
AI summary · MRNA is a long-term bullish holding: AI cuts cancer-target selection from 60 days to two weeks, enabling faster, cheaper cancer treatment. The October 24 Saturday Phase 3 presentation is the nearest catalyst and could disappoint; MRNA depends on this single treatment, and a bad report could send it back to the bottom.

Moderna has a meeting coming up this Saturday. It will be a presentation, and they deliberately do this when the market is closed. It will be a presentation on October 24th. This is the closest catalyst, an update to their Phase 3 cancer treatment data,

So, what does Moderna do? Moderna basically says: " Hey, let's examine someone's cancer. We'll take a solid cell from the cancer, and we'll surgically remove part of it. We'll take a biopsy."

So, we're going to take a biopsy of, you know, a cancer cell. And then, what we're going to do is genome sequencing...oh my god. We will be doing a genome sequence for that, which, as you know, is a very long series of genetic data.

Think of the letters T, A, and C. Remember your biology days, right? What we will try to do is try to find in that cancer cell parts of its genome that we can target to destroy it, which of course means that we do not want to target parts of that genome that, if targeted, could kill you.

Obviously, this is a problem. We want to target parts of that genome that are unique to that cancer cell . The problem is that cancer cells mutate all the time. It's constantly changing.

Therefore, this basic genome changes a lot. Therefore, what we will do is target 32 different parts. If any one of these parts survives, we will still be able to target that cancer cell.

What we will do is we will inject these small parts into your body, perhaps seven times over a 12-month course. We will train your body. We won't go into the exact science behind it, because it gets a bit complicated with protein folding and predicting what ultimately happens inside your lymph nodes.

Simply put, there are small carriers, okay? These small carriers will be trained on these thirty-two parts . These thirty-two small parts will be taken and attached to its outer surface.

You will take it to your lymphatic system and say to it, "Do you see all these little bumps we have here? Eliminate them. Eliminate these little proteins we are carrying. Identify them and eliminate them."

And then your lymphatic system will say: "We don't like this. We're going to ...we're going to ...we're going to... make a face. There we go . A face. We're going to go after those little bumps."

Well, these bumps are really hard to identify, and that's where artificial intelligence comes in. Because they can travel throughout your entire body, locate them, track down that cancerous cell and eliminate it to prevent it from spreading to the rest of your body, right?

The whole idea is that even if that cancer cell is mutating or evolving, as long as we have one of those remaining parts , we can still identify it. That's the idea. The problem is that this selection process used to take about 60 days, and you would only get two of them.

Maybe only two parts. Good? That has changed thanks to artificial intelligence. Now artificial intelligence comes along and says, "We can do a lot of this in about two weeks." We can get 32 expected chips that we actually believe will: first, eliminate cancer, and second, will not end your life.

Both things are somewhat important, aren't they? Therefore, artificial intelligence speeds up the time it takes to do this,

Showing 8 / 10 on this page
See this ticker’s full history